Purchases and Sales Made in Q2 2022 in Biond Vax Pharmaceuticals Ltd. (BVXV)
This table provides information about the institutional ownership of Biond Vax Pharmaceuticals Ltd. (BVXV) during Q2 2022. The information is specifically focused on institutions that hold shares of BiondVax Pharmaceuticals Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 03, 2022
Q2 2022
|
Envestnet Asset Management Inc
|
BUY
|
- |
113K+ 226.81% |
$132K - $213K
|
163K
$105K
|
|
|
Aug 12, 2022
Q2 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
18.3KNew |
$21.2K - $34.4K
|
18.3K
$11.7K
|
|
|
Jul 28, 2022
Q2 2022
|
True Private Wealth Advisors
|
BUY
|
- |
6K+ 12.12% |
$6.96K - $11.3K
|
55.5K
$35.5K
|
|
|
Aug 01, 2022
Q2 2022
|
Aspire Private Capital, LLC
|
BUY
|
- |
800+ 100.0% |
$928 - $1.5K
|
1.6K
$1.02K
|
|
|
Aug 09, 2022
Q2 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-1.19KClosed |
$1.38K - $2.24K
|
0
$0
|
|
|
Aug 10, 2022
Q2 2022
|
Citigroup Inc
|
SELL
|
- |
-2KClosed |
$2.32K - $3.76K
|
0
$0
|
|
|
Aug 10, 2022
Q2 2022
|
Ubs Group Ag
|
SELL
|
- |
-5.6K- 54.42% |
$6.5K - $10.5K
|
4.69K
$3K
|
|
|
Aug 15, 2022
Q2 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-14.4K- 30.13% |
$16.6K - $27K
|
33.3K
$21.3K
|
|
|
Oct 27, 2022
Q2 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-14.4K- 30.13% |
$16.6K - $27K
|
33.3K
$21.3K
|
|
|
Aug 15, 2022
Q2 2022
|
Two Sigma Securities, LLC
New York, NY |
SELL
|
- |
-22.9KClosed |
$26.6K - $43.1K
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-45.2K- 80.23% |
$52.4K - $85K
|
11.1K
$7.13K
|